Ipamorelin Peptide 5mg

Ipamorelin Peptide – Selective Growth Hormone Secretagogue for Advanced Endocrine Research

Introducing Ipamorelin Peptide, a highly selective synthetic pentapeptide and potent growth hormone secretagogue (GHS) designed to mimic ghrelin and selectively stimulate the release of endogenous growth hormone (GH) from the pituitary gland. With the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (molecular weight ≈711.9 Da), ipamorelin stands out for its specificity: it activates the ghrelin/growth hormone secretagogue receptor (GHS-R) without significantly elevating cortisol, prolactin, ACTH, or other stress-related hormones—unlike many earlier GHRPs.

This clean, targeted profile makes ipamorelin a preferred tool in preclinical and laboratory studies exploring GH physiology, somatotropic axis modulation, aging processes, body composition dynamics, and regenerative mechanisms.

Key Research Applications & Observed Effects:

• Potent & Selective GH Release — Triggers natural, pulsatile GH secretion (and subsequent IGF-1 elevation) in a dose-dependent manner, supporting investigations into growth hormone dynamics without broad hormonal disruption.
• Lean Muscle & Tissue Growth — Promotes protein synthesis, satellite cell activation, and muscle fiber regeneration via GH/IGF-1 pathways—ideal for muscle hypertrophy, recovery, and sarcopenia models.
• Fat Metabolism & Body Composition — Enhances lipolysis, reduces adiposity (especially visceral fat), and supports metabolic efficiency in energy balance and obesity-related research.
• Recovery & Repair Support — Aids in tissue healing, bone growth (e.g., longitudinal bone elongation in models), and connective tissue restoration; explored for injury, wound, and anti-aging studies.
• Sleep & Vitality Enhancement — May improve sleep architecture and energy levels through GH-mediated effects on circadian rhythms and overall homeostasis.
• Favorable Safety Profile — Minimal impact on cortisol, prolactin, or ACTH in comparative models, offering a cleaner pharmacological window than non-selective secretagogues.

Product Highlights:

• High-purity synthetic ipamorelin (≥98% purity, HPLC-verified)
• Lyophilized white powder for stability and easy reconstitution
• Available in research-grade vials (e.g., 2 mg, 5 mg, 10 mg+)
• Short half-life (~2 hours) for precise, pulsatile dosing protocols; often studied in combination with GHRH analogs (e.g., CJC-1295) for synergistic effects